XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2
License Agreements - Additional Information (Details)
$ / shares in Units, $ in Thousands
Oct. 19, 2020
USD ($)
Product
$ / shares
shares
Aug. 03, 2020
USD ($)
Product
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
License Agreements [Line Items]        
Number of licensed products obliged to develop and commercialize | Product 1 1    
Upfront payment shares issued | shares     39,575,454 39,430,120
Upfront payment value     $ 4 $ 4
Mirati Therapeutics, Inc        
License Agreements [Line Items]        
Number of period the agreement in effect   10 years    
Mirati Therapeutics, Inc | Private Placement | Common Stock        
License Agreements [Line Items]        
Upfront payment shares issued | shares   588,235    
Upfront payment value   $ 13,000    
Issue price per share | $ / shares   $ 34.00    
Premium percentage   10.00%    
Stock transfer restrictions period   18 months    
Voronoi Inc. | Development And Regulatory Milestone        
License Agreements [Line Items]        
License agreement maximum milestone payment obligation to pay     111,000  
Voronoi Inc. | Commercial Milestone        
License Agreements [Line Items]        
License agreement maximum milestone payment obligation to pay     225,000  
Voronoi Inc. | Success Based Milestones        
License Agreements [Line Items]        
License agreement, additional milestone payment     $ 272,000  
Voronoi Inc. | Private Placement | Common Stock        
License Agreements [Line Items]        
Upfront payment shares issued | shares 283,259      
Upfront payment value $ 6,800      
Issue price per share | $ / shares $ 28.24      
Premium percentage 25.00%      
Upfront cash payment $ 5,000